
Sign up to save your podcasts
Or


My guest this week is James Lanthier, CEO of Mindset Pharma of Toronto, Canada, a company that is seeking to develop novel psychedelic analogues to existing psychedelics such as psilocybin, DMT, and 5-MeO-DMT for more targeted delivery, efficacy, and therapeutic potential for use in the developing psychedelic healthcare field. You can find them online at www.mindsetpharma.com
By Martin W. Ball4.1
106106 ratings
My guest this week is James Lanthier, CEO of Mindset Pharma of Toronto, Canada, a company that is seeking to develop novel psychedelic analogues to existing psychedelics such as psilocybin, DMT, and 5-MeO-DMT for more targeted delivery, efficacy, and therapeutic potential for use in the developing psychedelic healthcare field. You can find them online at www.mindsetpharma.com

3,415 Listeners

328 Listeners

1,838 Listeners

1,288 Listeners

370 Listeners

309 Listeners

8,361 Listeners

1,646 Listeners

472 Listeners

280 Listeners

167 Listeners

29,130 Listeners

262 Listeners

9,996 Listeners

616 Listeners